ATEL Capital Group

Lightship is a provider of enterprise-level, direct-to-patient clinical research solutions. The company engages patients at home from recruitment through completion and eliminates the hurdles and inefficiencies of traditional approaches. Founded in 2018, Lightship is based in El Segundo, California.

Plant Prefab specializes in the construction of custom single and multifamily homes, emphasizing sustainability and health. The company offers a patented prefabricated building system that streamlines the construction process, significantly reducing build time compared to traditional methods. By collaborating with individuals, architects, and small developers, Plant Prefab provides efficient solutions for those looking to realize their housing projects. Clients can choose to work with their own architects, select from a range of standard designs, or engage with the company's design partners. As the first home factory in the United States dedicated exclusively to sustainable practices, Plant Prefab focuses on minimizing the environmental impact of home construction, including energy, water, and resource usage. The firm aims to ensure that homes are built with durability in mind, promoting a healthy living environment for residents while also reducing disruptions typically associated with on-site construction.

Emulate, Inc. specializes in developing organs-on-chips technology that emulates human biology to better understand the effects of diseases, medications, and environmental factors on human health. The company offers organ-chips that replicate the functions of various organs, including the lung, intestine, liver, and skin, and can simulate both normal and disease states. Emulate’s platform aims to provide more accurate predictions of human responses compared to traditional experimental methods, such as cell cultures or animal testing. The company serves a diverse clientele that includes biotechnology and pharmaceutical firms, consumer health and cosmetics companies, government agencies, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. It has shifted its focus towards advancing product innovation and safety across multiple sectors, including drug development and personalized medicine.

Emulate, Inc. specializes in developing organs-on-chips technology that emulates human biology to better understand the effects of diseases, medications, and environmental factors on human health. The company offers organ-chips that replicate the functions of various organs, including the lung, intestine, liver, and skin, and can simulate both normal and disease states. Emulate’s platform aims to provide more accurate predictions of human responses compared to traditional experimental methods, such as cell cultures or animal testing. The company serves a diverse clientele that includes biotechnology and pharmaceutical firms, consumer health and cosmetics companies, government agencies, and academic researchers. Founded in 2013 and based in Boston, Massachusetts, Emulate was previously known as Emulate Living MicroDevices, Inc. It has shifted its focus towards advancing product innovation and safety across multiple sectors, including drug development and personalized medicine.

Edeniq Inc. is a biotechnology company specializing in the conversion of cellulosic biomass into industrial sugars and cellulosic ethanol. Founded in 2006 and headquartered in Visalia, California, the company has developed innovative technologies, including the Cellunator, a device that enhances starch extraction from corn, and the Intellulose platform, which allows for the production of cellulosic ethanol from corn kernel fiber. Edeniq's solutions are designed for easy integration into existing ethanol production facilities without requiring significant capital investment. The company licenses its technologies to bio-refineries in the United States and Brazil, helping them improve efficiency and increase the yield of valuable biofuels and biochemicals.

iPierian is engaged in the research and development of therapies aimed at treating neurodegenerative diseases, including spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Alzheimer's disease. The company utilizes induced pluripotent stem cells to facilitate drug discovery and development, focusing on addressing significant unmet medical needs. In particular, iPierian is developing therapies and monoclonal antibodies that target Tauopathies, which are diseases characterized by the accumulation of tau protein in the brain. These therapies aim to slow the spread of tau throughout the brain, thereby inhibiting the progression of associated diseases.

SolFocus's mission is to enable solar energy generation at a Levelized Cost of Energy (LCOE) competitive with traditional fossil fuel sources. To achieve this goal, SolFocus has developed leading concentrator photovoltaic (CPV) technology which combines high-efficiency solar cells (approaching 40%) and advanced optics to provide solar energy solutions which are scalable, dependable and capable of delivering on the promise of clean, low-cost, renewable energy.

NexPlanar Corporation manufactures chemical mechanical planarization (CMP) pads specifically for the semiconductor device industry. Utilizing proprietary nano-domain technology and patented molded grooves, the company designs hard, mid-hard, and ultra-soft pads that enhance yields and reduce costs through extended pad life. Founded in 2003 and headquartered in Hillsboro, Oregon, NexPlanar also operates a manufacturing facility in Hopkins, Minnesota. The company's products are essential for preparing semiconductor wafers by ensuring a smooth surface prior to the deposition of additional layers of electrical circuits. As of 2015, NexPlanar operates as a subsidiary of Cabot Microelectronics Corporation.

IntelePeer is a provider of cloud-based communication solutions, focusing on enhancing business communications through its CPaaS-based platform. The company offers a range of services, including enterprise voice, SIP trunking, and cloud contact center solutions. By integrating AI and analytics, IntelePeer's platform enables businesses to improve customer interactions and drive revenue growth. Its omnichannel approach allows for seamless communication across various channels, facilitating better decision-making and customer satisfaction. The platform is designed to work effortlessly with existing business systems, making it a versatile choice for enterprises looking to enhance their communication capabilities.

Dimension Data, formerly known as OpSource, specializes in cloud and managed hosting solutions designed to help businesses of all sizes accelerate growth and scale operations while effectively managing costs and mitigating IT infrastructure risks. The company serves over four hundred clients, including Software-as-a-Service independent software vendors, cloud platform providers, carriers, and enterprises, who rely on its expertise and agility for high-availability, business-critical hosting environments. Dimension Data's Application Operations service enhances traditional hosting by offering comprehensive application management, change management, performance management, and application optimization. Its cloud solution combines the flexibility and community of public cloud services with the security, performance, and control needed by enterprises. Established in 2002, Dimension Data maintains certifications such as SAS 70 Type II, PCI DSS Level 1, and European Safe Harbor, with operations in the United States, the United Kingdom, Ireland, and India.

Enerkem Inc., a development stage company, focuses on the development and production of renewable biofuels and chemicals from waste. The company primarily focuses on the commercial production of cellulosic ethanol. Its proprietary thermochemical process converts waste into biofuels and chemicals. The company has a strategic partnership with NOVA Chemicals Corporation. The company is based in Montreal, Canada.

Innovalight, founded by Conrad Burke, specializes in the development of high-efficiency, low-cost solar modules utilizing a unique silicon ink technology. This innovative approach, which has been in development since 2005, allows for the processing of silicon in a liquid form, significantly enhancing the cost and efficiency of solar power generation. Innovalight's focus is on creating ultra-thin film power modules suitable for both residential and commercial applications, contributing to a manufacturing paradigm shift in the solar industry. By emphasizing the use of silicon-based solar cells, the company aims to improve the accessibility and effectiveness of grid-connected solar power solutions.

BuyerLink LLC operates online marketing platform for the acquisition of locally-targeted and category-specific consumers. It provides Enhanced Clicks, which represents a consumer who expresses interest in a specific product or service. The company’s widgets include automotive, real estate, home improvement, mortgage, travel, and insurance. It serves advertisers and publishers. BuyerLink LLC was formerly known as Reply.com and changed its name to BuyerLink LLC in October 2015. The company was founded in 2001 and is based in Walnut Creek, California. BuyerLink LLC operates as a subsidiary of One Planet Ops Inc.

Cornice, Inc. provides storage elements for consumer electronics devices. Its storage element is built into various consumer products, including mobile phones, MP3 players, personal video recorders, GPS devices, and portable storage products. The company offers Crash Guard, which consists of active latch, skip control, and drop safe. It serves consumer electronics manufacturers. The company was founded in 2000 and is headquartered in Longmont, Colorado with integration centers in Hong Kong, Japan, and Taiwan.

ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.